Business
Willow Biosciences and Cellular Goods Announce Multiyear Supply Agreement for Cannabigerol (CBG)
Willow Biosciences and Cellular Goods Announce Multiyear Supply Agreement for Cannabigero...
About this update from Atlas Energy Corp.
[{"type":"text","content":"\n \n \n \n Willow Biosciences and Cellular Goods Announce Multiyear Supply Agreement for Cannabigerol (CBG)\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n VANCOUVER, BC\n \n ,\n \n June 10, 2021\n \n /CNW/ - Willow Biosciences Inc. (\"\n \n Willow\n \n \" or the \"\n \n Company\n \n \") (TSX: WLLW) (OTCQX: CANSF), a biotechnology company producing ultra-pure, sustainably made compounds, and Cellular Goods PLC (\"\n \n Cellular Goods\n \n \") (LSE: CBX), a U.K. based provider of premium consumer products based on biosynthetically made cannabinoids, are announcing today that the two companies have signed a multi-year supply agreement, whereby Willow will supply Cellular Goods with its proprietary, ultra-pure, biosynthetically produced, cannabigerol (\"\n \n Willow\n \n \n CBG\n \n \") to be used in Cellular Goods' premium cannabinoid-based skin care products to be launched in autumn of 2021.\n \n \n \n \n \n \n \n \n \n The Company's first shipment of Willow CBG to Cellular Goods is expected to arrive in July of this year.\n \n \n In\n \n April 2021\n \n , Willow announced that it has completed a series of studies with its development partner, Signum Biosciences, Inc., that demonstrate the safety and anti-inflammatory, anti-aging, and antimicrobial properties of Willow CBG on human skin. These results, coupled with the sustainable and safe manufacturing nature of Willow's manufacturing process, make Willow CBG an ideal core ingredient for cosmetics in the evolving regulatory landscape of the\n \n United Kingdom\n \n .\n \n \n In\n \n May 2021\n \n , the European Commission declared that CBG had been added to the European Union cosmetic ingredients database (named \"CosIng\"), approving the compound as safe for use in personal care and cosmetics products. European manufacturers of personal care and cosmetics products can now use CBG in their products with the approval of a major market regulator for trade in the European Union.\n \n \n \n Alexis Abraham\n \n , Cellular Goods Chief Executive Officer, said: \"Successful...